Anest. intenziv. Med. 2003;14(6):259-261

Levobupivacaine - Dosing Scheme in Paediatric AnaesthesiaArticles

V. Mixa
Klinika anesteziologie a resuscitace, UK, 2. LF a IPVZ, FN Motol, Praha, přednosta doc. MUDr. K. Cvachovec, CSc.

Regional anaesthesia is increasingly used in combined anaesthesia and for continuous postoperative analgesia. Next tobupivacaine, its levorotatory enantiomer - levobupivacaine - has been recently used more frequently. The efficacy of thisnew local anaesthetic drug is comparable with that of bupivacaine, however, its neurotoxicity and cardiotoxicity aresignificantly lower. Therefore, levobupivacaine seems to be a suitable anaesthetic drug for newborn babies and smallchildren in which, in case of inaccurate administration, the risk of fatal complication is quite high. In the article we presenta survey of dosage of levobupivacaine for paediatric patients. These data have only been sporadically reported so far.Drawn-up survey of dosage of levobupivacaine has been based on evaluation of data available in literature and our ownexperience. Maximum single dose for caudal and lumbar block is 2 mg/kg and 1.25 mg/kg for thoracic block.The continuousregimen dosage is based on the following scheme: 0.2 mg/kg/hour for newborns and 0.3-0.4 mg/kg/hour for older children.The citied authors differ slightly in doses and concentrations of the local anaesthetic used for the respective levels of accessinto the epidural space. The opinion prevails that administration of levobupivacaine to children of all age categories is basedon approved indications for bupivacaine.

Keywords: regional anaesthesia of children; levobupivacaine; cardiotoxicity; neurotoxicity; dosage of levobupivacainein children

Published: December 1, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mixa V. Levobupivacaine - Dosing Scheme in Paediatric Anaesthesia. Anest. intenziv. Med. 2003;14(6):259-261.
Download citation




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.